See all our coronavirus coverage
Ecuador has approved the use of AstraZeneca’s Covid-19 vaccine, the country’s health ministry said on Sunday.
The vaccine, developed with Oxford University, is the second that the country’s regulator has registered for use. The Pfizer vaccine is being rolled out through a pilot programme to medical personnel and in nursing homes since last week.
“The agency authorized imports of approximately five million doses of the AstraZeneca Covid-19 vaccine, which will be applied to 2.5 million Ecuadoreans,” the ministry added in a statement. “It will allow Ecuador to strengthen the process of containing the disease to achieve herd immunity.”
France imposed new border restrictions on Sunday as part of its bid to contain the spread of Covid-19.
Starting Sunday, arrivals to France from European Union countries by air or sea must be able to produce a negative PCR test result obtained in the previous 72 hours. The requirement had already applied to non-EU arrivals since mid-January.
EU travellers entering France by land, including cross-border workers, will not need a negative test.Continue reading...